Haberman Yael, Di Segni Ayelet, Loberman-Nachum Nurit, Barel Ortal, Kunik Vered, Eyal Eran, Kol Nitzan, Hout-Siloni Goni, Kochavi Brigitte, Avivi Camila, Schvimer Michael, Rechavi Gideon, Anikster Yair, Barshack Iris, Weiss Batia
*Division of Pediatric Gastroenterology, Hepatology and Nutrition, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel †Cincinnati Children's Hospital Medical Center, Cincinnati, OH ‡Cancer Research Center §Institute of Pathology, Sheba Medical Center, Tel Hashomer ||Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv ¶Metabolic Disease Unit, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
J Pediatr Gastroenterol Nutr. 2017 May;64(5):770-776. doi: 10.1097/MPG.0000000000001424.
Congenital diarrheal disorders is a group of inherited enteropathies presenting in early life and requiring parenteral nutrition. In most cases, genetics may be the key for precise diagnosis. We present an infant girl with chronic congenital diarrhea that resolved after introduction of fructose-based formula but had no identified mutation in the SLC5A1 gene. Using whole exome sequencing (WES) we identified other mutations that better dictated dietary adjustments.
WES of the patient and her parents was performed. The analysis focused on recessive model including compound heterozygous mutations. Sanger sequencing was used to validate identified mutations and to screen the patient's newborn sister and grandparents. Expression and localization analysis were performed in the patient's duodenal biopsies using immunohistochemistry.
Using WES we identified a new compound heterozygote mutation in sucrase-isomaltase (SI) gene; a maternal inherited known V577G mutation, and a novel paternal inherited C1531W mutation. Importantly, the newborn offspring carried similar compound heterozygous mutations. Computational predictions suggest that both mutations highly destabilize the protein. SI expression and localization studies determined that the mutated SI protein was not expressed on the brush border membrane in the patient's duodenal biopsies, verifying the diagnosis of congenital sucrase-isomaltase deficiency (CSID).
The novel compound heterozygote V577G/C1531W SI mutations lead to lack of SI expression in the duodenal brush border, confirming the diagnosis of CSID. These cases of CSID extend the molecular spectrum of this condition, further directing a more adequate dietary intervention for the patient and newborn sibling.
先天性腹泻疾病是一组在生命早期出现且需要肠外营养的遗传性肠病。在大多数情况下,遗传学可能是精确诊断的关键。我们报告一名患有慢性先天性腹泻的女婴,在引入基于果糖的配方奶后腹泻得到缓解,但在SLC5A1基因中未发现突变。通过全外显子组测序(WES),我们鉴定出了其他能更好地指导饮食调整的突变。
对患者及其父母进行了WES。分析集中在隐性模式,包括复合杂合突变。使用桑格测序法验证鉴定出的突变,并对患者的新生妹妹和祖父母进行筛查。使用免疫组织化学在患者的十二指肠活检组织中进行表达和定位分析。
通过WES,我们在蔗糖酶 - 异麦芽糖酶(SI)基因中鉴定出一种新的复合杂合突变;一个来自母亲的已知V577G突变,以及一个来自父亲的新的C1531W突变。重要的是,新生后代携带类似的复合杂合突变。计算预测表明这两种突变都使蛋白质高度不稳定。SI表达和定位研究确定突变的SI蛋白在患者十二指肠活检组织的刷状缘膜上未表达,从而证实了先天性蔗糖酶 - 异麦芽糖酶缺乏症(CSID)的诊断。
新的复合杂合子V577G/C1531W SI突变导致十二指肠刷状缘缺乏SI表达,证实了CSID的诊断。这些CSID病例扩展了这种疾病的分子谱,进一步指导了对患者和新生兄弟姐妹更适当的饮食干预。